ewsba.se
CelLBxHealth PLC (AIM:CLBX, FRA:DWV) is in advanced talks with one of the largest private US healthcare providers to deploy its Parsortix cancer diagnostic platform. In a first quarter trading update, the company guided for revenues of at least £2.1 million this year, a 50% increase, with further upgrades possible if pipeline deals convert.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) has secured a Canadian patent for its POLB 001 drug candidate in preventing cancer immunotherapy-induced cytokine release syndrome. CEO Jeremy Skillington says the grant strengthens the drug's appeal to partners ahead of interim trial data expected this summer.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) lifted EBITDA 50% to $33.87 million in the first quarter as a gold price of $4,816 per ounce more than offset lower production at its Blanket mine. Free cash flow more than doubled and the board has approved a quarterly dividend of 14 cents per share.
Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) has raised £8 million from existing institutional investors to accelerate development at its Pitfield Titanium Project in Western Australia. The company now has around £14.5 million in cash and says its planned ASX dual listing remains on track for the second half of 2026.
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) has secured its 20% stake in Namibia's PEL 93 on an unconditional basis while cutting around $15 million of future funding obligations. The company retains exposure to a potentially basin-opening play while keeping its focus on its priority Alaskan assets.
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) has consented to Elevra Lithium transferring its 22.5% interest in the Ewoyaa Lithium Project in Ghana to Zhejiang Huayou Cobalt. The move is expected to simplify funding and accelerate development of what could be Ghana's first lithium mine.